Against this backdrop, a team led by Professor Zhang Han and Associate Professor Chen Zhi from Shenzhen University in China , has demonstrated an innovative approach that combines DNA origami, CRISPR ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
The introduction of GALEAS uPCR: ESR1 assay marks another milestone in our mission to see a world where non-invasive cancer testing is available to everyone.” — Jeff Bousfield, CEO of Nonacus ...
A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Carlsberg has patented a method using digital PCR to identify specific nucleotide mutations in mutated genes. The process involves mutagenizing a pool of organisms, dividing them into sub-pools, and ...
Scientists at Rady Children's Institute for Genomic Medicine, and the Department of Neurosciences and Pediatrics at the University of California, San Diego, have made a significant breakthrough in ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
The model suggests that negative KRAS findings are believable when the maximum of APC and TP53 frequencies is at least 8% (corresponding posterior probability of false negative <5%). Validation ...